Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Touat

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Cell Reports|October 5, 2021
Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere modelsMax A Stockslager, Seth Malinowski, Mehdi Touat, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2019
PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisitedSamuel Knauss, Corinna Preusse, Yves Allenbach, et al.
Neuro-Oncology Advances|August 16, 2021
Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemicFernando Lozano-Sanchez, Renata Ursu, Anna Luisa Di-Stefano, et al.
Journal of Neuro-Oncology|September 9, 2022
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesionHenri Malaizé, Florence Laigle-Donadey, Maximilien Riche, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
NPJ Precision Oncology|December 1, 2022
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI responseIsaias Hernández-Verdin, Kadir C Akdemir, Daniele Ramazzotti, et al.
The Oncologist|July 28, 2025
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinibFederico Villanacci, Diego Prost, Francesco Pieri, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
Bioinformatics (Oxford, England)|November 28, 2020
Quantification of aneuploidy in targeted sequencing data using ASCETSLiam F Spurr, Mehdi Touat, Alison M Taylor, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with BevacizumabSamy Ammari, Raoul Sallé de Chou, Tarek Assi, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Cell Reports|October 5, 2021
Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere modelsMax A Stockslager, Seth Malinowski, Mehdi Touat, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2019
PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisitedSamuel Knauss, Corinna Preusse, Yves Allenbach, et al.
Neuro-Oncology Advances|August 16, 2021
Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemicFernando Lozano-Sanchez, Renata Ursu, Anna Luisa Di-Stefano, et al.
Journal of Neuro-Oncology|September 9, 2022
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesionHenri Malaizé, Florence Laigle-Donadey, Maximilien Riche, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
NPJ Precision Oncology|December 1, 2022
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI responseIsaias Hernández-Verdin, Kadir C Akdemir, Daniele Ramazzotti, et al.
The Oncologist|July 28, 2025
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinibFederico Villanacci, Diego Prost, Francesco Pieri, et al.
NPJ Precision Oncology|June 19, 2026
Clinical responses to trastuzumab deruxtecan in molecularly defined ependymomaL Nicolas Gonzalez Castro, Yi-Chien Wu, Jia-Ren Lin, et al.
Bioinformatics (Oxford, England)|November 28, 2020
Quantification of aneuploidy in targeted sequencing data using ASCETSLiam F Spurr, Mehdi Touat, Alison M Taylor, et al.
Diagnostics (Basel, Switzerland)|August 7, 2021
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with BevacizumabSamy Ammari, Raoul Sallé de Chou, Tarek Assi, et al.
Pageof 10